BLRX BioLineRx Ltd
Company Analysis
Latest News
🟢 BioLineRx is trading 7.8% up today on no clear news
BioLineRx is trading 7.8% up at $3.04 on no clear news, appearing to move on idiosyncratic trading or a low-float swing. • No company-specific catalysts were...
🟢 BioLineRx is trading 6.5% up today on continued momentum from recent licensing and financing deals
BioLineRx is trading 6.5% up at $3.02 on continued momentum from recent licensing and financing deals. • Sentiment remains supported by a recent licensing...
🔴 BioLineRx is trading 5.8% down today on sector-wide risk-off sentiment
BioLineRx is trading 5.8% down at $2.92 today as the stock gives back recent gains amid a broader biotechnology sector pullback. • The decline aligns with...
🔴 BioLineRx is trading 7.7% down today on profit-taking and broader biotech volatility
BioLineRx is trading 7.7% down at $2.86 in pre-market action, pulling back as investors lock in profits following recent gains in the clinical-stage biopharma...
BioLineRx Drops 11% on a Risk-Off Day — Can Promising Cancer Data Overcome Small-Cap Biotech's Credibility Problem?
Shares of BioLineRx slid 11% to $2.81 in early trading July 8, erasing gains the Israeli biotech had built over the prior week, as a broad retreat from riskier...
🔴 BLRX is trading 11% down today as risk-off sentiment offsets positive GLIX1 data
BLRX is trading 11% down at $2.81 as broader market weakness and risk-off sentiment in the small-cap biotech sector outweigh positive clinical news. •...
🔴 BLRX Dips 12.03% Amid Broader Market Sell-Off, BioLineRx Announces Positive GLIX1 Preclinical Data in Ovarian Cancer
• BLRX is trading at $2.78, down 12.03% from yesterday's close, as broader market risk-off sentiment impacts stocks. • This decline comes despite BioLineRx...